2005年3月第3期
·07/05/10 Subjective Visual Vertical in Pitch and Roll in Right Hemispheric Stroke
·07/05/10 Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults
·07/05/10 Assessment of Cardiac Structure and Left Atrial Appendage Functions in Primary Antiphospholipid Syndrome
·07/05/10 Improving Trial Power Through Use of Prognosis-Adjusted End Points
·07/05/10 Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
·07/05/10 A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke
·07/05/10 Tuftsin Fragment 1–3 Is Beneficial When Delivered After the Induction of Intracerebral Hemorrhage
·07/05/10 Motor Impairment and Recovery in the Upper Limb After Stroke
·07/05/10 Efficacy and Safety of Nimodipine in Subcortical Vascular Dementia
·07/05/10 Decline in Physical Performance Among Women With a Recent Transient Ischemic Attack or Ischemic Stroke
·07/05/10 Performance of the PHQ-9 as a Screening Tool for Depression After Stroke
·07/05/10 Depression Among Caregivers of Stroke Survivors
·07/05/10 The Mexican-American Coronary Artery Disease Family Study
·07/05/10 Public Awareness of Warning Symptoms, Risk Factors, and Treatment of Stroke in Northwest India
·07/05/10 Inosine Reduces Ischemic Brain Injury in Rats
·07/05/10 Effects of Fosinopril and Pravastatin on Carotid Intima-Media Thickness in Subjects With Increased Albuminuria
·07/05/10 Intracerebral Hemorrhage in the Iron-Deficient Rat
·07/05/10 Hyperthermia Masks the Neuroprotective Effects of Tissue Plaminogen Activator
·07/05/10 Reduction of Cerebral Infarction in Stroke-Prone Spontaneously Hypertensive Rats by Statins Associated With Amelioration of Oxidative Stress
·07/05/10 Soluble CD40L and Cardiovascular Risk in Asymptomatic Low-Grade Carotid Stenosis
·07/05/10 Magnetic Resonance Perfusion Tracks 133Xe Cerebral Blood Flow Changes After Carotid Stenting
·07/05/10 Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke
·07/05/10 Localized Reversible Reduction of Apparent Diffusion Coefficient in Transient Hypoglycemia-Induced Hemiparesis
·07/05/10 Left Ventricular Mass Indexed to Height and Prevalent MRI Cerebrovascular Disease in an African American Cohort
·07/05/10 The Pathophysiology of Watershed Infarction in Internal Carotid Artery Disease
·07/05/10 Priorities for Clinical Research in Intracerebral Hemorrhage
·07/05/10 A Description of Canadian and United States Physician Reimbursement for Thrombolytic Therapy Administration in Acute Ischemic Stroke
·07/05/10 Prevalence of Stroke Among Chinese, Malay, and Indian Singaporeans
·07/05/10 Effects of High Altitude Exposure on Cerebral Hemodynamics in Normal Subjects
·07/05/10 Radiographic Measures of Chronic Periodontitis and Carotid Artery Plaque
·07/05/10 Disorders of Sleep and Wake in Patients After Subarachnoid Hemorrhage
·07/05/10 Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
·07/05/10 Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults
·07/05/10 Assessment of Cardiac Structure and Left Atrial Appendage Functions in Primary Antiphospholipid Syndrome
·07/05/10 Improving Trial Power Through Use of Prognosis-Adjusted End Points
·07/05/10 Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
·07/05/10 A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke
·07/05/10 Tuftsin Fragment 1–3 Is Beneficial When Delivered After the Induction of Intracerebral Hemorrhage
·07/05/10 Motor Impairment and Recovery in the Upper Limb After Stroke
·07/05/10 Efficacy and Safety of Nimodipine in Subcortical Vascular Dementia
·07/05/10 Decline in Physical Performance Among Women With a Recent Transient Ischemic Attack or Ischemic Stroke
·07/05/10 Performance of the PHQ-9 as a Screening Tool for Depression After Stroke
·07/05/10 Depression Among Caregivers of Stroke Survivors
·07/05/10 The Mexican-American Coronary Artery Disease Family Study
·07/05/10 Public Awareness of Warning Symptoms, Risk Factors, and Treatment of Stroke in Northwest India
·07/05/10 Inosine Reduces Ischemic Brain Injury in Rats
·07/05/10 Effects of Fosinopril and Pravastatin on Carotid Intima-Media Thickness in Subjects With Increased Albuminuria
·07/05/10 Intracerebral Hemorrhage in the Iron-Deficient Rat
·07/05/10 Hyperthermia Masks the Neuroprotective Effects of Tissue Plaminogen Activator
·07/05/10 Reduction of Cerebral Infarction in Stroke-Prone Spontaneously Hypertensive Rats by Statins Associated With Amelioration of Oxidative Stress
·07/05/10 Soluble CD40L and Cardiovascular Risk in Asymptomatic Low-Grade Carotid Stenosis
·07/05/10 Magnetic Resonance Perfusion Tracks 133Xe Cerebral Blood Flow Changes After Carotid Stenting
·07/05/10 Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke
·07/05/10 Localized Reversible Reduction of Apparent Diffusion Coefficient in Transient Hypoglycemia-Induced Hemiparesis
·07/05/10 Left Ventricular Mass Indexed to Height and Prevalent MRI Cerebrovascular Disease in an African American Cohort
·07/05/10 The Pathophysiology of Watershed Infarction in Internal Carotid Artery Disease
·07/05/10 Priorities for Clinical Research in Intracerebral Hemorrhage
·07/05/10 A Description of Canadian and United States Physician Reimbursement for Thrombolytic Therapy Administration in Acute Ischemic Stroke
·07/05/10 Prevalence of Stroke Among Chinese, Malay, and Indian Singaporeans
·07/05/10 Effects of High Altitude Exposure on Cerebral Hemodynamics in Normal Subjects
·07/05/10 Radiographic Measures of Chronic Periodontitis and Carotid Artery Plaque
·07/05/10 Disorders of Sleep and Wake in Patients After Subarachnoid Hemorrhage
·07/05/10 Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage